Area of Research: PARP Inhibitors
2020 Grant Recipients
-
Nidhi Sahni, PhD,
MD Anderson Cancer Center
Liz Tilberis Early Career AwardSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
-
Janice Santiago, PhD,
MD Anderson Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardCrizotinib Improves the Therapeutic Efficacy of Olaparib in Ovarian Cancer
2019 Grant Recipients
-
Sarah Gitto, PhD,
University of Pennsylvania
Ann and Sol Schreiber Mentored Investigator AwardModeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
-
Marilyne Labrie, PhD,
Oregon Health and Science University
Ann and Sol Schreiber Mentored Investigator AwardSynergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
-
Shariska Petersen, MD,
University of Kansas Medical Center Research Institute
Ann and Sol Schreiber Mentored Investigator AwardCyclin E and BRD4 as Markers for a New PARPi Drug Combination
2018 Grant Recipients
-
Shih-Hsun Chen, PhD,
Beckman Research Institute of the City of Hope
Ann and Sol Schreiber Mentored Investigator AwardTargeting de-poly (ADP-ribosyl)ation for Ovarian Cancer Therapy
-
Maria Victoria Botuyan, PhD,
Mayo Clinic
Liz Tilberis Early Career AwardProbing the Antagonistic Roles of 53BP1 and RAD18 in HR DNA Repair
-
Jian Yuan, PhD,
Mayo Clinic
Liz Tilberis Early Career AwardThe Role of BRD9-Rad51 Axis in Chemoresistance in Ovarian Cancer
2017 Grant Recipients
-
Anniina Farkkila, MD, PhD,
Dana Farber Cancer Institute
Ann and Sol Schreiber Mentored Investigator AwardOvercoming PARP Inhibitor Resistance in Ovarian Cancer
2015 Grant Recipients
-
Sarah Adams, MD,
University of New Mexico
Liz Tilberis Early Career AwardA Combination Therapy for Hereditary Ovarian Cancer
2014 Grant Recipients
-
Barbara Stulken Norquist, MD,
University of Washington
Liz Tilberis Early Career AwardMolecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
-
Mo Li, PhD,
University of Michigan
Ann and Sol Schreiber Mentored Investigator AwardMechanism of PARP Inhibitor in Ovarian Cancer Therapy Cancer
2013 Grant Recipients
-
Elizabeth Swisher, MD,
University of Washington
Collaborative Research Development GrantThe FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas
2012 Grant Recipients
-
See-Hyoung Park, PhD,
Stanford University
Ann and Sol Schreiber Mentored Investigator AwardTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
-
Sarah Adams, MD,
University of Pennsylvania
Liz Tilberis Early Career AwardDevelopment of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
2008 Grant Recipients
-
Lejla Delic, MD,
Cedars-Sinai Medical Center
Ann and Sol Schreiber Mentored Investigator AwardA New Class of Drugs with Potential Against Ovarian Cancer: PARP-inhibitors